Colorectal Cancer
Program eliminates gender disparities, boosts colonoscopy rates among Hispanic patients
A culturally tailored patient navigation program improved colorectal cancer screening rates and reduced the gender gap in screenings among Hispanic patients, according to results published in Cancer.
Top in hem/onc: Malignant brain tumor treatment, colorectal cancer in younger adults
Researchers have made progress toward developing treatments for malignant brain tumors, but experts said it has been challenging to test multiple agents in clinical trials.
Weight loss during systemic therapy linked to shorter survival in colorectal cancer
Weight loss during the first 3 months of systemic therapy for metastatic colorectal cancer coincided with significantly shorter OS compared with stable or increasing weight, according to study results.
Cabozantinib plus durvalumab shows efficacy in subset of patients with colorectal cancer
The combination of cabozantinib and durvalumab appeared safe and demonstrated efficacy among a small cohort of patients with advanced mismatch repair-proficient/microsatellite-stable colorectal cancer, according to study results.
Nivolumab regimen misses PFS endpoint but shows promise in metastatic colorectal cancer
First-line nivolumab plus standard of care chemotherapy failed to prolong 1-year PFS among patients with metastatic colorectal cancer, according to study results presented at ASCO Gastrointestinal Cancers Symposium.
Increase in distant-stage early colorectal cancer highest among younger age groups
Individuals aged between 20 and 39 years had the greatest burden of distant early-onset colorectal adenocarcinoma, according to a retrospective study published in Cancer Epidemiology, Biomarkers & Prevention.
Three-drug combination active in metastatic colorectal cancer subset
A three-drug combination demonstrated activity for patients with microsatellite-stable, BRAF V600E-positive metastatic colorectal cancer, according to study results presented at ASCO Gastrointestinal Cancers Symposium.
VIDEO: Financial barriers to CRC screening reduced, thanks to new guidelines
In a Healio video exclusive, John Inadomi, MD, president of the American Gastroenterological Association, outlined the Biden administration’s new guidance requiring private insurers to cover the cost of follow-up colonoscopy.
HF may be tied to cancer incidence, mortality in those 50 years and older
HF may be associated with cancer incidence as well as risk for cancer-related mortality, especially among individuals aged 50 to 70 years, according to new data published in JACC: CardioOncology.